Advertisement
Advertisement
U.S. markets open in 5 hours 23 minutes
Advertisement
Advertisement
Advertisement
Advertisement

iBio, Inc. (IBIO)

NYSE American - NYSE American Delayed Price. Currency in USD
Add to watchlist
0.2510-0.0189 (-7.00%)
At close: 04:00PM EDT
0.2574 +0.01 (+2.55%)
After hours: 07:59PM EDT
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Inside Bar (Bullish)

Inside Bar (Bullish)

Previous Close0.2699
Open0.2549
Bid0.0000 x 900
Ask0.0000 x 900
Day's Range0.2489 - 0.2799
52 Week Range0.2400 - 1.7600
Volume3,456,221
Avg. Volume2,291,648
Market Cap54.739M
Beta (5Y Monthly)-5.38
PE Ratio (TTM)N/A
EPS (TTM)-0.1320
Earnings DateMay 12, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est1.75
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for IBIO

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • iBio, Inc.
    Weekly Stock ListMarkets have faced difficult times before, with challenging economic environments, wars, disease, banking and housing crises, and inflation much worse than we are seeing now, to name but a few. Of late, stock investors had it very good for a very long time -- but now, finding opportunities requires much more work. There is no secret sauce, but there are principals that are worth reviewing: 1) diversify; 2) look for strong management; 3) look for solid balance sheets; 4) do your homework; and 5) adapt. To assemble this week's list, we looked across several sectors that historically are considered to be the most-shielded from high inflation and high interest rates. We then cross-referenced our coverage universe for companies where our analysts recently raised target prices; that have an Argus Financial Strength rating of at least Medium-High; and that pay dividends of least 3%. Some companies also are featured in our model portfolios (Growth & Income, Equity Income, Growth, and Institutional). Here is our list of companies we believe to be recession-proof, all of which are rated BUY at Argus.
    Rating
    Fair Value
    Economic Moat
    7 days agoArgus Research
View more
Advertisement
Advertisement